Owkin and AWS Partners to Propel Personalized Medicine with AI

The partnership combines AWS’s cloud technology and Owkin’s AI expertise to drive precision medicine and drug discovery. 

Owkin, a TechBio company blending human and artificial intelligence (AI) to advance personalized medicine, has announced a collaboration with Amazon Web Services (AWS) to revolutionize the fields of drug discovery, clinical trials acceleration and the development of AI-driven diagnostics. This partnership is set to leverage AWS’s extensive global infrastructure and cloud capabilities to enhance Owkin’s data handling, optimize operational efficiency and propel precision medicine research.

“Owkin was founded with the belief that the future of precision medicine is in technologies that are able to unlock insights from the vast amount of patient data in hospitals and research centers in a privacy-preserving and secure way,” shared Thomas Clozel, the CEO of Owkin. He emphasized the importance of collaboration and expressed excitement about teaming up with AWS to harness the cloud’s power and flexibility for research initiatives.

Innovating biotechnology with AI and cloud computing

The collaboration focuses on pushing the envelope in biotechnological innovation by utilizing AWS’s high-performance computing, machine learning tools and scalable cloud infrastructure. This synergy will enable Owkin to fulfill its substantial data storage requirements, craft generative AI applications and refine foundational models. 

With tools like Amazon SageMaker, Owkin plans to develop, train and deploy machine learning models more efficiently, process high-quality data at scale and enhance the delivery of its AI solutions to research partners, pathology laboratories and the biopharmaceutical industry. The ultimate goal is to improve patient health outcomes through these innovative approaches. 

Leveraging expertise for precision medicine

Both Owkin and AWS will pool their expertise—Owkin’s in biotech research and development and AWS’s Healthcare and Life Sciences team’s experience in various health sectors—to tackle the critical challenges in precision medicine and tailor treatments to individual patients. 

Dan Sheeran, General Manager of Healthcare and Life Sciences at AWS, highlighted the transformative potential of cloud technology and generative AI in accelerating healthcare innovation. “We are excited to support Owkin in their journey to lower costs and discover and develop better, more targeted treatments faster with flexible, secure and scalable infrastructure and fit for purpose generative AI tools,” he added.

Advanced infrastructure for cutting-edge research

Owkin will utilize AWS’s robust infrastructure for deploying its applications, including the Amazon Elastic Compute Cloud (Amazon EC2) UltraClusters equipped with NVIDIA H100 Tensor Core GPUs, to access supercomputing capabilities on demand. This setup is designed to significantly reduce the time required for training machine learning models. 

Furthermore, Owkin plans to explore AWS’s specialized cloud-oriented chips, like AWS Trainium for machine learning acceleration and AWS Graviton for general-purpose computing, aiming for optimal performance and cost-efficiency across various workloads.

Commitment to data sovereignty and security

Emphasizing data sovereignty, Owkin will benefit from AWS’s Digital Sovereignty Pledge, ensuring complete control over their data with stringent sovereignty controls, including encryption and data residency guardrails. This will facilitate secure partnerships and high-quality data collaboration while adhering to comprehensive compliance controls and standards, supporting global regulatory requirements. 

Also read: 

Header Image from Pexels Press release link: https://press.aboutamazon.com/aws/2024/2/techbio-unicorn-owkin-teams-up-with-aws-to-advance-generative-ai-for-precision-medicine

SHARE THIS STORY

Share on facebook
Share on twitter
Share on linkedin
Share on email

RELATED POSTS

Step Into Tomorrow: Explore the Wonders of InnoEX 2024 in Hong Kong

In the bustling city of Hong Kong, where over seven million people reside, the call for smarter, more livable cities is louder than ever. This April, the Hong Kong Trade Development Council (HKTDC) steps up to answer that call with the InnoEX and the landmark 20th edition of the HKTDC Hong Kong Electronics Fair (Spring Edition) (EFSE). Backed by the visionary efforts of the HKSAR Government Innovation, Technology and Industry Bureau and the HKTDC, these tech expos are set to feature the latest and greatest innovation from over 3000 exhibitors from more than 20 nations and regions. 

Cloud Software Group and Microsoft Forge Strategic Cloud and AI Partnership

Cloud Software Group Inc. and Microsoft Corp. have announced an expansion of their long-standing collaboration through an eight-year strategic partnership. This partnership aims to strengthen the go-to-market collaboration for the Citrix virtual application and desktop platform and facilitate the development of new cloud and AI solutions. As part of the agreement, Cloud Software Group will commit US$1.65 billion to Microsoft’s cloud services and generative AI capabilities.

The Best 4 Hardware Crypto Wallets of 2024

After a long crypto winter since the spring of 2022, the crypto world has been buzzing with activity recently. In January, the U.S. saw the approval of Bitcoin ETFs; on March 14, Bitcoin’s price soared to an all-time high of US$73,835—obviously, there is an upsurge in interest in the crypto market. 

SUNRATE Empowers B2B Transactions with Apple Pay Integration

SUNRATE, a global payment and treasury management platform for businesses, announced the integration of Apple Pay for its customers, offering a safer and more private payment method. This move leverages the advanced security features of the iPhone to protect transactions and aligns with the growing demand for seamless and secure business transactions.